Dr. Andrew Christian Elden, MD

Dr. Elden practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Elden's NPI, 1528401270, was assigned on April 12, 2013. Dr. Elden graduated from Rutgers New Jersey Medical School in 2013. Dr. Elden holds Florida license ME128002.

Dr. Elden's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Elden's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Elden to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elden practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Elden's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Elden is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Elden's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis, hemorrhoids and irritable bowel syndrome (IBS) among the conditions Dr. Elden treats.

CMS data shows 394 Medicare services from Dr. Elden across 8 procedure codes in 2024, for 214 Medicare patients. Medicare paid $37,550 for them.

CMS counts 214 Medicare patients who saw Dr. Elden in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elden's median patient age at 53, with 62% women.

In 2024, Dr. Elden wrote 753 Medicare Part D claims for 247 patients. 79% of them were for generic drugs. CMS names the drug for 656 of them, across 19 drugs with 11 or more claims each, at $189,389 in total drug cost. In 2023, CMS named 497 claims across 15 drugs.

Dr. Elden accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Elden as offering telehealth. CMS counts 73 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Elden, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Elden. Dr. Elden's most frequent co-authors are Lauren B. Elman, MD, Robert Wolfe Greene, MD, PhD and Virginia L. Lee, MD.

CMS Open Payments shows 65 general payments to Dr. Elden from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Olympus Corporation of the Americas paid the most, $1,025. It also lists 2 research payments totaling $123 in 2017.

Dr. Elden graduated from Rutgers New Jersey Medical School in 2013. Dr. Elden is a member of ACG, AGA and ASGE.

Dr. Elden is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.